Michael G. Backlund
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Cannabis and Cannabinoid Research
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 11
- Inflammatory mediators and NSAID effects 10
-
- Cancer, Lipids, and Metabolism 6
- NF-κB Signaling Pathways 2
- Co-authors
- Raymond N. DuBois (9 shared papers)Jason R. Mann (6 shared papers)Vijaykumar Holla (4 shared papers)Sudhansu K. Dey (3 shared papers)F. Gregory Buchanan (2 shared papers)Ginger L. Milne (2 shared papers)Erik S. Musiek (2 shared papers)Dingzhi Wang (3 shared papers)
- Journals
- Cancer Research (3 papers)Journal of Clinical Microbiology (2 papers)Journal of Biological Chemistry (2 papers)Oncology (1 paper)Expert Opinion on Therapeutic Targets (1 paper)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Michael G. Backlund
18 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Pharmacology 551
- Biochemistry 128
- Cancer Research 219
- Molecular Medicine 39
- Applied Microbiology and Biotechnology 15
Countries citing papers authored by Michael G. Backlund
This map shows the geographic impact of Michael G. Backlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Backlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Backlund more than expected).
Fields of papers citing papers by Michael G. Backlund
This network shows the impact of papers produced by Michael G. Backlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Backlund. The network helps show where Michael G. Backlund may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael G. Backlund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 240 | |
| 2 | 2008 | 138 | |
| 3 | 2005 | 124 | |
| 4 | 2005 | 87 | |
| 5 | 2006 | 85 | |
| 6 | 2005 | 80 | |
| 7 | 2008 | 70 | |
| 8 | 2008 | 68 | |
| 9 | 2011 | 57 | |
| 10 | 2008 | 47 | |
| 11 | 2022 | 23 | |
| 12 | 2006 | 15 | |
| 13 | 2009 | 14 | |
| 14 | 2013 | 14 | |
| 15 | 2016 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2019 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2023 | 0 |
About Michael G. Backlund
Michael G. Backlund is a scholar working on Pharmacology, Cancer Research, Molecular Biology, Genetics and Oncology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Cancer, Lipids, and Metabolism (6 papers), Estrogen and related hormone effects (5 papers), Antibiotic Resistance in Bacteria (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), NF-κB Signaling Pathways (2 papers), Pancreatic function and diabetes (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Pharmacology (551 citations), Biochemistry (128 citations), Cancer Research (219 citations), Molecular Medicine (39 citations) and Applied Microbiology and Biotechnology (15 citations). Michael G. Backlund has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Raymond N. DuBois, Jason R. Mann, Vijaykumar Holla, Sudhansu K. Dey, F. Gregory Buchanan, Ginger L. Milne, Erik S. Musiek, Dingzhi Wang, Hsin-Hsiung Tai and Sharada Katkuri. Their work appears in journals such as Cancer Research, Journal of Clinical Microbiology, Journal of Biological Chemistry, Oncology and Expert Opinion on Therapeutic Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.